The US Senate has confirmed Erica Schwartz, MD, JD, MPH, as the new Director of the Centers for Disease Control and Prevention (CDC), following a 51–44 vote.
Schwartz brings extensive experience in federal health leadership. She previously served as Deputy Surgeon General of the United States and as Chief Medical Officer of the US Coast Guard. Her confirmation comes after a period of significant leadership changes at the CDC.
During her Senate confirmation hearing, Schwartz emphasized her commitment to scientific integrity, telling lawmakers:
“I will never betray the science.”
Her appointment also carries significance for cancer prevention and control in the United States. The CDC supports programs addressing major cancer risk factors, including tobacco use and secondhand smoke exposure, while also contributing to cancer screening, surveillance, data collection and prevention initiatives across the country.
Following the confirmation, Lisa Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), highlighted the importance of the CDC’s role in reducing the cancer burden.
“CDC must continue its unwavering commitment to science and prevention.”
ACS CAN said it stands ready to work with Director Schwartz and her team to continue advancing evidence-based cancer prevention and public health efforts nationwide.
Read also on OncoDaily: Senate Acts to Keep Politics Out of Cancer Research Funding
